Spruce Biosciences Stock Forecast

SPRB's stock price has decreased by -82.43% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Spruce Biosciences stock have an average target of 1.75, with a low estimate of 0.50 and a high estimate of 3.00. The average target predicts an increase of 1,322.76% from the current stock price of 0.12.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$0.50	$1.75	$3.00	$3.00
Change	+306.50%	+1322.8%	+2339.0%	+2339.0%

Analyst Ratings

The average analyst rating for Spruce Biosciences stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	0	0	0	0	0	0
Buy	2	0	0	0	0	0
Hold	5	7	7	7	7	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Gregory Renza RBC Capital	RBC Capital	Hold Maintains $1.5 → $0.5	Hold	Maintains	$1.5 → $0.5	+306.50%	Apr 16, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Dec 16, 2024
Evan Wang Guggenheim	Guggenheim	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Dec 12, 2024
Jonathan Wolleben JMP Securities	JMP Securities	Buy → Hold Downgrades $3	Buy → Hold	Downgrades	$3	+2,339.02%	Dec 11, 2024
Gregory Renza RBC Capital	RBC Capital	Hold Reiterates $2 → $1.5	Hold	Reiterates	$2 → $1.5	+1,119.51%	Dec 11, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

2.04M

from 4.91M

-58.46%

from 4.91M

Revenue Next Year

8.42M

from 2.04M

312.50%

from 2.04M

EPS This Year

-0.58

from -1.29

EPS Next Year

-0.66

from -0.58

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	10.09M	4.91M	2.04M	8.42M	10.97M
Revenue Growth	-	-	-	-	-51.32%	-58.46%	312.50%	30.30%
EPS	-4.93	-1.81	-1.96	-1.24	-1.29	-0.58	-0.66	-1.09
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	6	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	6.3M	12.1M	17.3M
Avg	2.0M	8.4M	11.0M
Low	n/a	4.9M	4.9M

Revenue Growth

Revenue Growth	2025	2026	2027
High	28.3%	491.9%	105.9%
Avg	-58.5%	312.5%	30.3%
Low	-	140.2%	-41.8%

EPS Forecast

EPS	2025	2026	2027
High	-0.28	-0.18	-0.46
Avg	-0.58	-0.66	-1.09
Low	-0.90	-1.45	-1.66

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.